Cyclacel Pharmaceuticals, Inc.

DB:UXI Stock Report

Market Cap: €2.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cyclacel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:UXI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Dec 23Buy€18,305Spiro RombotisIndividual6,070€3.02
21 Dec 23Buy€5,688Paul McBarronIndividual1,886€3.02

Insider Trading Volume

Insider Buying: UXI insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of UXI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8070.0612%
Individual Insiders77,1645.85%
Hedge Funds82,0326.22%
Institutions152,84011.6%
General Public1,005,41476.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 57.7%.


Top Shareholders

Top 25 shareholders own 23.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.39%
The Lind Partners, LLC
84,250€188.0k0%0.8%
6.22%
Altium Capital Management LP
82,032€183.1k116%0.11%
2.19%
Spiro Rombotis
28,899€64.5k3.49%no data
1.84%
Acadian Asset Management LLC
24,223€54.1k0%no data
1.19%
Paul McBarron
15,685€35.0k3.51%no data
1.16%
Point72 Asset Management, L.P.
15,333€34.2k0%no data
1.1%
Renaissance Technologies LLC
14,438€32.2k16.8%no data
0.96%
Mark Kirschbaum
12,630€28.2k4.6%no data
0.44%
The Vanguard Group, Inc.
5,796€12.9k0%no data
0.44%
Geode Capital Management, LLC
5,761€12.9k0%no data
0.32%
Karin Walker
4,172€9.3k0.24%no data
0.32%
Samuel Barker
4,155€9.3k-0.14%no data
0.31%
Christopher Henney
4,089€9.1k-0.12%no data
0.31%
Robert Jay Spiegel
4,073€9.1k-0.1%no data
0.17%
Kenneth Ferguson
2,197€4.9k56.3%no data
0.14%
Schonfeld Strategic Advisors LLC
1,900€4.2k0.37%no data
0.096%
Brian Schwartz
1,264€2.8k-69.6%no data
0.063%
McIlrath & Eck, LLC
832€1.9k-0.12%no data
0.061%
Tower Research Capital LLC
807€1.8k238%no data
0.0096%
Osaic Wealth, Inc. , Asset Management Arm
126€281.3-73.5%no data
0.0061%
Morgan Stanley, Investment Banking and Brokerage Investments
80€178.60%no data
0.0025%
Wells Fargo & Company, Securities and Brokerage Investments
33€73.60%no data
0.0019%
BlackRock, Inc.
25€55.9-92%no data
0.0015%
SignatureFD, LLC
20€44.70%no data
0.00099%
Harbour Investments, Inc.
13€29.10%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.